Tekla Life Sciences Investors Statistics
Share Statistics
Tekla Life Sciences Investors has -
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding | n/a |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 33.54% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 138 |
FTD / Avg. Volume | 0.1% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
PE Ratio | 0 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | n/a |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tekla Life Sciences Investors.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | 0 |
Quick Ratio | 0 |
Debt / Equity | 0 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | undefined |
Asset Turnover | 0.19 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -5.56% in the
last 52 weeks. The beta is 0.77, so Tekla Life Sciences Investors's
price volatility has been higher than the market average.
Beta | 0.77 |
52-Week Price Change | -5.56% |
50-Day Moving Average | 12.66 |
200-Day Moving Average | 14.11 |
Relative Strength Index (RSI) | 57.24 |
Average Volume (20 Days) | 135,319 |
Income Statement
In the last 12 months, Tekla Life Sciences Investors had revenue of 86.69M
and earned 85.3M
in profits. Earnings per share was 0.
Revenue | 86.69M |
Gross Profit | 86.69M |
Operating Income | 85.3M |
Net Income | 85.3M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 0 |
Full Income Statement Balance Sheet
The company has 1 in cash and 0 in
debt, giving a net cash position of 1.
Cash & Cash Equivalents | 1 |
Total Debt | n/a |
Net Cash | n/a |
Retained Earnings | 44.13M |
Total Assets | 460.58M |
Working Capital | 281.61K |
Full Balance Sheet Margins
Gross margin is 100%, with operating and profit margins of 98.4% and 98.4%.
Gross Margin | 100% |
Operating Margin | 98.4% |
Pretax Margin | 98.4% |
Profit Margin | 98.4% |
EBITDA Margin | n/a |
EBIT Margin | 98.4% |
FCF Margin | n/a |